No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARδ and PPARγ act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma-Reference-Cited by-同舟云学术

No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARδ and PPARγ act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma

Published:2005-10 Issue:10 Volume:15 Page:713-721
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

McGreavey Louise E.,Turner Faye,Smith Gillian,Boylan Katherine,Timothy Bishop D.,Forman David,Roland Wolf C.,Barrett Jennifer H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference55 articles.

1. Reaction thresholds to pressure in edematous hindpaw of rats and response to analgesic drugs;Winter;J Pharmacol Exp Ther,1965

2. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents;Kurumbail;Nature,1996

3. A hypothesis: non-steroidal anti-inflammatory drugs reduce the incidence of large bowel cancer;Rosenberg;J Natl Cancer Inst,1991

4. A randomized trial of aspirin to prevent colorectal adenomas;Baron;N Engl J Med,2003

5. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case–control study of subjects participating in the Nottingham faecal occult blood screening programme;Logan;BMJ,1993

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility;In Vivo;2022

2. CYP2 C9 polymorphism among patients with oral squamous cell carcinoma and its role in altering the metabolism of benzo[a]pyrene;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2020-09

3. Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors;Archives of Toxicology;2020-05-15

4. An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding;Expert Opinion on Drug Metabolism & Toxicology;2020-03-29

5. Cytochrome P450 epoxygenases and cancer: A genetic and a molecular perspective;Pharmacology & Therapeutics;2019-04